ANI Pharmaceuticals (NASDAQ:ANIP) Beats Expectations in Strong Q4 CY2025, Stock Jumps 12.4% [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
The company's full-year revenue guidance of $1.09 billion at the midpoint came in 4.8% above analysts' estimates. Its non-GAAP profit of $2.33 per share was 17.9% above analysts' consensus estimates. Is now the time to buy ANI Pharmaceuticals? Find out in our full research report ANI Pharmaceuticals (ANIP) Q4 CY2025 Highlights: Revenue: $247.1 million vs analyst estimates of $231 million (29.6% year-on-year growth, 6.9% beat) Adjusted EPS: $2.33 vs analyst estimates of $1.98 (17.9% beat) Adjusted EBITDA: $65.36 million vs analyst estimates of $62.07 million (26.5% margin, 5.3% beat) Adjusted EPS guidance for the upcoming financial year 2026 is $9.09 at the midpoint, beating analyst estimates by 5.1% EBITDA guidance for the upcoming financial year 2026 is $282.5 million at the midpoint, above analyst estimates of $260.7 million Operating Margin: 14.1%, up from -2.3% in the same quarter last year Market Capitalization: $1.61 billion “2025 was a year of significant gr
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals Q4 2025: Strong Growth, But Execution Risks Emerge [Seeking Alpha]Seeking Alpha
- ANI Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Inc (ANIP) Q4 2025 Earnings Call Highlights: Record Revenue and Strong ... [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals, Inc. (ANIP) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- ANI Pharma (ANIP) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
ANIP
Earnings
- 2/27/26 - Beat
ANIP
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- 3/3/26 - Form 4
- ANIP's page on the SEC website